Author:
Yokoyama Masayuki,Shiraishi Kouichi
Reference92 articles.
1. Yokoyama, M., Okano, T.: Targetable drug carriers: present status and a future perspective. Adv. Drug Deliv. Rev. 21, 77 (1996)
2. Sugiyama, Y.: Importance of pharmacokinetic considerations in the development of drug delivery systems. Adv. Drug. Deliv. Rev. 19, 333 (1996)
3. Maeda, H.: SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy. Adv. Drug Deliv. Rev. 46(1–3), 169–185 (2001)
4. Kroon, J., Metselaar, J.M., Storm, G., van der Pluijm, G.: Liposomal nanomedicines in the treatment of prostate cancer. Cancer Treat Rev (in print)
5. Cao, H., Yamamoto, K., Yang, L.X., Weber, R.: Brentuximab vedotin: first-line agent for advanced Hodgkin lymphoma. Anticancer Res. 33(9), 3879–3885 (2013)